Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Daoussis

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Clinical Rheumatology|April 17, 2010
Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammationDimitrios Daoussis, Vasileios F Panoulas, Holly John, et al.
Clinical Immunology (Orlando, Fla.)|August 2, 2019
A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosisGeorgios Efthymiou, Efthymios Dardiotis, Christos Liaskos, et al.
Medicina (Kaunas, Lithuania)|September 27, 2025
Intravenous Immunoglobulin in Acute Exacerbations of Fibrotic Interstitial Lung Diseases: A Retrospective, Real-World StudyVasilina Sotiropoulou, Eva Theochari, Matthaios Katsaras, et al.
BMC Psychiatry|July 18, 2023
Low cognitive functioning and depressive symptoms in patients with rheumatoid arthritis and systemic sclerosis: a clinical studyPanagiotis Alexopoulos, Maria Skondra, Marina Charalampopoulou, et al.
Frontiers in Immunology|December 25, 2018
Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic SclerosisAthanasios Gkoutzourelas, Christos Liaskos, Maria G Mytilinaiou, et al.
Rheumatology (Oxford, England)|April 29, 2020
An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging findingDimitrios Daoussis, Pantelis Kraniotis, Alexandra Filippopoulou, et al.
Seminars in Arthritis and Rheumatism|November 15, 2016
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung diseaseDimitrios Daoussis, Konstantinos Melissaropoulos, Georgios Sakellaropoulos, et al.
Rheumatology International|July 19, 2020
A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodiesAthanasios Gkoutzourelas, Christos Liaskos, Theodora Simopoulou, et al.
Joint Bone Spine|July 15, 2021
The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: A meta-analysisLoukas Kakoullis, Fotios Sampsonas, Vasileios Karamouzos, et al.
Autoimmunity Reviews|May 20, 2026
Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort studyAnastasia Chioni, Corrado Campochiaro, Shiri Keret, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Clinical Rheumatology|April 17, 2010
Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammationDimitrios Daoussis, Vasileios F Panoulas, Holly John, et al.
Clinical Immunology (Orlando, Fla.)|August 2, 2019
A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosisGeorgios Efthymiou, Efthymios Dardiotis, Christos Liaskos, et al.
Medicina (Kaunas, Lithuania)|September 27, 2025
Intravenous Immunoglobulin in Acute Exacerbations of Fibrotic Interstitial Lung Diseases: A Retrospective, Real-World StudyVasilina Sotiropoulou, Eva Theochari, Matthaios Katsaras, et al.
BMC Psychiatry|July 18, 2023
Low cognitive functioning and depressive symptoms in patients with rheumatoid arthritis and systemic sclerosis: a clinical studyPanagiotis Alexopoulos, Maria Skondra, Marina Charalampopoulou, et al.
Frontiers in Immunology|December 25, 2018
Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic SclerosisAthanasios Gkoutzourelas, Christos Liaskos, Maria G Mytilinaiou, et al.
Rheumatology (Oxford, England)|April 29, 2020
An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging findingDimitrios Daoussis, Pantelis Kraniotis, Alexandra Filippopoulou, et al.
Seminars in Arthritis and Rheumatism|November 15, 2016
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung diseaseDimitrios Daoussis, Konstantinos Melissaropoulos, Georgios Sakellaropoulos, et al.
Rheumatology International|July 19, 2020
A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodiesAthanasios Gkoutzourelas, Christos Liaskos, Theodora Simopoulou, et al.
Joint Bone Spine|July 15, 2021
The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: A meta-analysisLoukas Kakoullis, Fotios Sampsonas, Vasileios Karamouzos, et al.
Autoimmunity Reviews|May 20, 2026
Nintedanib combined with dual immunosuppression for interstitial lung disease in systemic sclerosis and rheumatoid arthritis: A systematic review and pooled multicentre real-world cohort studyAnastasia Chioni, Corrado Campochiaro, Shiri Keret, et al.
Pageof 11